NYSE:CANO

Cano Health (CANO) Stock Forecast, Price & News

$0.25

-0.02 (-6.80%)

(As of 12:16 PM ET)

Compare

Today's Range: $0.25
▼
$0.28
50-Day Range: $0.22
▼
$1.73
52-Week Range: $0.22
▼
$9.75

Volume: 2.63 million shs
Average Volume: 8.13 million shs
Market Capitalization: $137.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.08

Cano Health MarketRank™ Forecast

Analyst Rating: Reduce
1.89 Rating Score
Upside/Downside: 673.9% Upside
$2.08 Price Target
Short Interest: Bearish
15.38% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.45
Based on 6 Articles This Week
Insider Trading: Selling Shares
$23,597 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.80) to ($0.26) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

727th out of 965 stocks

Offices & Clinics Of Medical Doctors Industry

5th out of 6 stocks

2.9

Analyst's Opinion

Consensus Rating
Cano Health has received a consensus rating of Reduce. The company's average rating score is 1.89, and is based on no buy ratings, 8 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $2.08, Cano Health has a forecasted upside of 673.9% from its current price of $0.27.
Amount of Analyst Coverage
Cano Health has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
15.38% of the float of Cano Health has been sold short.
Short Interest Ratio / Days to Cover
Cano Health has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Cano Health has recently increased by 8.90%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Cano Health does not currently pay a dividend.
Dividend Growth
Cano Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CANO.

1.9

News and Social Media Coverage

News Sentiment
Cano Health has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Cano Health this week, compared to 4 articles on an average week.
Search Interest
Only 11 people have searched for CANO on MarketBeat in the last 30 days. This is a decrease of -76% compared to the previous 30 days.
MarketBeat Follows
Only 22 people have added Cano Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -4% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cano Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,597.00 in company stock.
Percentage Held by Insiders
16.41% of the stock of Cano Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 35.99% of the stock of Cano Health is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Cano Health are expected to grow in the coming year, from ($0.80) to ($0.26) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cano Health is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cano Health is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cano Health has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Cano Health (NYSE:CANO) Stock

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.

CANO Price History

30 days | 90 days | 365 days | Advanced Chart

CANO Stock News Headlines

October 2, 2023 | bizjournals.com

Cano Health CFO departs, interim named

September 29, 2023 | marketwatch.com

Cano Health Names Eladio Gil Interim CFO

October 4, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

September 29, 2023 | finance.yahoo.com

Cano Health Announces Change in Chief Financial Officer Role

September 28, 2023 | axios.com

Scoop: Cano Health piecemeal breakup continues

September 28, 2023 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Gritstone Oncology (GRTS) and Cano Health (CANO)

September 27, 2023 | msn.com

Cano Health sees interest for remainder of its primary care assets - report

September 27, 2023 | americanbankingnews.com

Investors Buy Large Volume of Call Options on Cano Health (NYSE:CANO)

October 4, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

September 27, 2023 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Ionis Pharmaceuticals (IONS) and Cano Health (CANO)

September 26, 2023 | finance.yahoo.com

Cano Health sells facilities in 2 states for $67 million

September 26, 2023 | finance.yahoo.com

Cano Health sells substantially all of its Primary Care Centers in Texas & Nevada to CenterWell Senior Primary Care

September 12, 2023 | seekingalpha.com

Cano Health receives NYSE notification letter; plans to regain compliance with listing rules

September 12, 2023 | finance.yahoo.com

Why Cano Health Stock Slid by Nearly 3% on Tuesday

September 11, 2023 | finance.yahoo.com

Cano Health Announces Plans for Regaining Compliance with NYSE Stock Price Criteria

August 29, 2023 | markets.businessinsider.com

Truist Financial Reaffirms Their Hold Rating on Cano Health (CANO)

August 21, 2023 | finance.yahoo.com

Cano Health names permanent CEO, founder leaves board

August 21, 2023 | finance.yahoo.com

Cano Health Appoints Mark Kent Permanent Chief Executive Officer

August 15, 2023 | msn.com

Credit Suisse Maintains Cano Health Inc - (CANO) Neutral Recommendation

August 14, 2023 | 247wallst.com

Citigroup Downgrades Cano Health

August 12, 2023 | msn.com

Cano Health Warns It May Not Be Able to Stay in Business, Looks for Buyer

August 12, 2023 | markets.businessinsider.com

Cano Health Announces Financial Results for the Second Quarter 2023

August 12, 2023 | barrons.com

Cano Health Stock Dives 49% After Warning About Its Future. It’s Looking for Buyers.

August 12, 2023 | msn.com

Cano Health Stock Dives 65% After Warning About Its Future

August 11, 2023 | msn.com

Cano plunges after going concern warning in Q2 results

August 11, 2023 | finance.yahoo.com

These Stocks Are Moving the Most Today: Cano Health, Maxeon Solar, IonQ, Lucid, and More

August 11, 2023 | finance.yahoo.com

Q2 2023 Cano Health Inc Earnings Call

See More Headlines

Receive CANO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cano Health and its competitors with MarketBeat's FREE daily newsletter.

CANO Company Calendar

Last Earnings: 8/10/2023
Today: 10/04/2023
Next Earnings (Estimated): 11/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Offices & clinics of medical doctors
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:CANO
CUSIP: N/A
CIK: 1800682
Web: canohealth.com
Phone: 855-226-6633
Fax: N/A
Employees: 4,365
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $2.08
High Stock Price Forecast: $4.00
Low Stock Price Forecast: $0.80
Forecasted Upside/Downside: +660.0%
Consensus Rating: Reduce
Rating Score (0-4): 1.89
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.47)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-207,270,000.00
Net Margins: -12.47%
Pretax Margin: -25.06%
Return on Equity: -13.40%
Return on Assets: -3.47%

Debt

Debt-to-Equity Ratio: 3.95
Current Ratio: 0.49
Quick Ratio: 0.49

Sales & Book Value

Annual Sales: $2.74 billion
Price / Sales: 0.05
Cash Flow: $0.83 per share
Price / Cash Flow: 0.33
Book Value: $1.00 per share
Price / Book: 0.27

Miscellaneous

Outstanding Shares: 538,680,000
Free Float: 450,286,000
Market Cap: $147.33 million
Optionable: Optionable
Beta: 0.30

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Brian D. Koppy (Age 54)
Chief Financial Officer
Comp: $333.9k

Mr. Bob Camerlinck (Age 56)
Chief Operating Officer
Comp: $471.5k

Mr. Mark Kent
CEO & Director

Mr. Mark Novell (Age 60)
Chief Accounting Officer

Eric Santiago
Chief Technology Officer

Ms. Amy Charley
Chief Admin. Officer

Frederick Green
Interim Chief Legal Officer

Ms. Jennifer Fernandez Hevia
Chief People Officer

Ms. Barbara Ferreiro
Chief Brand Officer

Mr. Pedro Cordero
Chief Population Health Office

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CANO Stock - Frequently Asked Questions

Should I buy or sell Cano Health stock right now?: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cano Health in the last year. There are currently 1 sell rating and 8 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CANO shares.
View CANO analyst ratings or view top-rated stocks.
What is Cano Health's stock price forecast for 2023?: 9 brokerages have issued 12 month target prices for Cano Health's stock. Their CANO share price forecasts range from $0.80 to $4.00. On average, they expect the company's stock price to reach $2.08 in the next year. This suggests a possible upside of 660.0% from the stock's current price.
View analysts price targets for CANO or view top-rated stocks among Wall Street analysts.
How have CANO shares performed in 2023?: Cano Health's stock was trading at $1.37 on January 1st, 2023. Since then, CANO shares have decreased by 80.0% and is now trading at $0.2735.
View the best growth stocks for 2023 here.
Are investors shorting Cano Health?: Cano Health saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 32,800,000 shares, an increase of 8.9% from the August 31st total of 30,120,000 shares. Based on an average trading volume of 11,180,000 shares, the short-interest ratio is currently 2.9 days. Currently, 15.4% of the shares of the company are short sold.
View Cano Health's Short Interest.
When is Cano Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our CANO earnings forecast.
How were Cano Health's earnings last quarter?: Cano Health, Inc. (NYSE:CANO) announced its quarterly earnings data on Thursday, August, 10th. The company reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.09) by $0.19. The firm earned $766.75 million during the quarter, compared to analysts' expectations of $837.65 million. Cano Health had a negative trailing twelve-month return on equity of 13.40% and a negative net margin of 12.47%.

What is Cano Health's stock symbol?: Cano Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CANO."
How do I buy shares of Cano Health?: Shares of CANO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Cano Health's stock price today?: One share of CANO stock can currently be purchased for approximately $0.27.
How much money does Cano Health make?: Cano Health (NYSE:CANO) has a market capitalization of $147.33 million and generates $2.74 billion in revenue each year. The company earns $-207,270,000.00 in net income (profit) each year or ($1.47) on an earnings per share basis.
How many employees does Cano Health have?: The company employs 4,365 workers across the globe.
How can I contact Cano Health?: Cano Health's mailing address is 1601 WASHINGTON AVENUE SUITE 800, MIAMI BEACH FL, 33139. The official website for the company is canohealth.com. The company can be reached via phone at 855-226-6633 or via email at canohealthir@westwicke.com.

This page (NYSE:CANO) was last updated on 10/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial